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Abreviation                              Meaning 
KTH            Khartoum Teaching Hospital  
SUH            Soba University Hospital 
KRT            Khartoum State 
APH            Antepartum Hemorrahge 
IUGR            Intra Uterine Growth Restriction  
LBW            Low Birth Weight 
1st 2nd 3rd trimester          first , second and third trimesters  
NCU            Neonatal care unit 
Anti-D           Anti-D-immunoglobulin 
HSV            Herpes simplex virus  
HCG                                        Human Chorionic Gonadotrophin hormone 
LH            Luteinizing hormone  
FSH            Follicle stimulating hormone  
TSH           Thyroid Stimulating Hormone 
E2           Oestrogen 
T4           Thyroxine  
T3           Triiodothyronine 
HPL           Human Placental Lactogen   
SPI           Specific Placental Immunoglobulin 
PAPP .A           Placenta Associated Plasma Protein A  
AFP           Alpha  Feto Protein  
ABSTARACT 
 
 
      This is a prospective cohort study conduced in the period from 
June 2003 to June 2004 . There were 308 patients attending  the out 
patient   , referred and casualty clinics in KTH and SUH . There were 103 
cases and 205 controls . 
      We studied  the effect of bleeding in the 1st and 2nd trimesters on the 
perinatal  outcome .  we looked specifically for the risk of prematurity ,   
intrauterine growth restriction , antepartum haemorrhage and the perinatal 
morbidity and mortality . 
     Other risks also appeared in the study including the risk of congenital 
malformations and the association with a previous history of infertility . 
   Those patients were followed from the time of vaginal bleeding which 
should be at 24 week gestational age or less . 
       The pregnancy should proceed to the third trimester . 
      Patients are seen regularly and at time of complications till delivery 
and discharge jointly with the neonatologist . 
     
 
 
IV 
The statistical analysis showed an increased risk of preterm labour 
and delivery which was statistically significant (P= .003). 
        It was even more significant for those who had more than one 
episode of bleeding compared to the control group .  
        For growth restriction , the study revealed   astatistically significant 
risk of baby born at term with growth restriction compared to the control 
group. 
       Also there was an increased risk of perinatal morbidity and mortality 
among cases  with early vaginal bleeding compared to controls ( P= 
.001). 
        Regarding the risk of antepartum haemorrahge , The P value = .004 , 
showing an increased risk of all forms of APH including unexplained 
antepartum haemorrahge . 
    Also there was an association between history of infertility and the risk 
of bleeding in early pregnancy .  
     There was no association between previous miscarriages and the 
occurrence of bleeding in early pregnancy  in the future .  
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Introduction 
           Human reproduction is arelatively inefficient process. Some 
investigators demonstrated that 57% of all conceptions advance beyond 
20 weeks. (1) Of those lost 75%occur before implantation, only 25% are 
clinically recognizable. Recent investigations have found an overall 
pregnancy loss of 31% with 22% occurring before implantation. 
Although the number of pregnancies wasted before implantation is very 
large, most of them are not recognized clinically, and in practice the 
problem of early pregnancy loss is limited to those pregnancies aborted 
after implantation. 
           Threatened miscarriage - vaginal bleeding before 20 gestational 
weeks - is the commonest complication in pregnancy, occurring in about 
a fifth of cases. (2) Miscarriage is 2.6 times as likely, and 17% of cases are 
expected to present complications later in pregnancy. Although general 
practitioners and gynaecologists often see this condition, management of 
threatened miscarriage is mostly empirical. Bed rest is routinely 
recommended, and about a third of women presenting with threatened 
miscarriage are prescribed drugs. However, two thirds of the general 
practitioners recommending this do not believe it affects outcome  
           Threatened miscarriage occurs often and is a serious emotional 
burden for women. (2) Sonographic evaluation at presentation can usually 
differentiate between intrauterine and extrauterine pregnancy and offer 
some prognostic clues. Demonstration of fetal heart activity is generally 
associated with a successful pregnancy rate of 85-97%, whereas an empty 
large gestational sac or a discrepancy between menstrual and sonographic 
age of more than a week indicates a poor prognosis. Advanced maternal  
age and increasing number of previous miscarriages deteriorates 
prognosis. 
           All forms of APH were significantly higher in term deliveries 
complicated by threatened miscarriage. (3)  Pregnancies presenting with 
threatened miscarriage should be highlighted as 'high risk'. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Literature review 
Definition:  
           The clinical diagnosis of threatened abortion is presumed when 
any bloody vaginal discharge or vaginal bleeding appears during the first 
half of pregnancy. (4)  It is an extremely commonplace occurrence, 
because one out of four or five pregnant women has vaginal spotting or 
heavier bleeding during early gestation. The bleeding and pain that 
accompany threatened abortion are not usually intense. Threatened 
abortion rarely manifests with severe vaginal bleeding. Often, the 
bleeding is temporary and self-limited and probably due to trophoblastic 
implantation within the decidualized endometrium (5) Threatened abortion 
is defined by the absence of passing/passed tissue and the presence of a 
closed cervical os. These findings differentiate threatened abortion from 
later stages of abortion.  
Risk factors: 
Maternal Age: 
           Older women are at increased risk of miscarriage in the general 
population.(6) A prospective study on women with threatened abortion 
reported that women older than 34 years had an odds ratio of 2.3 for 
miscarriage, however, the 95% confidence interval was wide (0.76 to 
7.10), and the contribution of maternal age in regression analysis was not 
significant (P = 0.13) 
 
 
 Previous miscarriage: 
           Having had previous miscarriages is also associated with increased 
risk in future pregnancies, especially in older women, whereas data from 
the general population show that the rate of fetal loss declines with 
advancing gestational age. (7)  
Aetiology: 
Subchorionic haematoma: 
           A relatively common cause of bleeding in the first half of 
pregnancy, but an uncommon cause of pregnancy loss, is the separation 
of foetal membranes.(1) The bleeding may occur between the chorion and 
amnion (chorioamniotic separation) or between the chorioamnion and the 
deciduas (subchorionic haematoma). Patient with these abnormalities 
have first trimester bleeding that may vary in severity. Usually they have 
minimal or no cramping. Ultrasound shows a normal active foetus and an 
area of membrane separation usually opposite to the placental 
implantation site. Often a thin membrane can be seen floating between 
the uterus and the foetus in cases of chorioamniotic separation. In 
subchorionic haematomas the membrane is thick and has limited mobility 
           The cause of such bleeding and membrane separation is unknown. 
The course of the problem is not related to the severity of the initial 
bleeding episode. However, estimation of the haematoma size by 
ultrasound seems to be of prognostic value. 
           There are some other etiological factors operating in spontaneous 
miscarriage: 
Genetic causes: 
           Genetic causes of miscarriage include chromosomal abnormalities, 
single gene defects and polygenic multifactorial conditions. (8) Snijders et 
al. estimated the prevalence of a range of chromosomal abnormalities at 
different gestations in relation to trisomy 21 in live births. For each 
chromosomal abnormality the authors were able to calculate the rate of 
intra-uterine lethality. For example, in trisomy 21, the rate of intra-uterine 
lethality between 12 and 14 weeks is 41% and between 16 and 40 weeks 
is 32%. The more severe the chromosomal abnormality, the earlier in 
gestation that lethality will occur. Other abnormalities such as non-
immune hydrops, neural tube defects and cardiac defects are associated 
with second trimester miscarriage.  
           Chromosome analysis was performed on 1,543 specimens of first 
trimester miscarriage received between 1982 and 1994. (9)  Comparisons 
with earlier studies show that some findings are absolutely consistent 
between different years and populations, but some major differences are 
also found. The results are considered in the light of several recent 
genetic, environmental and physiological studies. Trisomy 16, and 
probably trisomy 22, is entirely dependent on maternal age; other 
trisomies show both maternal age and other environmental or genetic 
effects. Monosomy X and mosaic aneuploidy arise postzygotically by 
chromosome loss, a normal control mechanism. Some trisomy, dipaternal 
triploidy and tetraploidy probably occur because of pre- or postovulatory 
'overripeness'; either due to transient or chronic maternal conditions or 
delayed fertilization. Unbalanced structural abnormalities, most 
apparently of de novo origin, are markedly increased compared to earlier 
studies and are possibly due to paternal environmental exposures. It is 
concluded that when considering histories of abortion, studies of the 
chromosomes of the aborted products are much more informative and 
cost-effective than studies of parental bloods. Where available, studies of 
products should be undertaken for preference, but only by experienced 
and committed laboratories.  
Serum factors: 
           The effect of serum from patients with threatened abortion on in 
vitro development of two-cell mouse embryos was evaluated.(10) Embryos 
were cultured for 72 hours in 7.5% serum supplement from patients with 
threatened abortion and from women with normal pregnancies and in 
Ham's F-10 medium with no serum supplement. Significantly fewer 
embryos developed to the blastocyst stage at 72 hours in the threatened 
abortion group as compared with the normal pregnancy group and Ham's 
F-10 (P < .001). These results suggest the presence of serum factors that 
are toxic to early embryonic development and thus may play a role in the 
pathogenesis of threatened abortion.  
Endocrine abnormalities: 
          The role of producing progesterone in early pregnancy is handled 
by the corpus luteum in response to stimulation by human chorionic 
gonadotropin (hCG) and is then taken over by the placenta by the end of 
the first trimester.(11) A defect in corpus luteum function results in 
decreased progesterone production and a higher likelihood of 
spontaneous abortion. Consequently, there has been much interest in the 
use of hCG to treat women with recurrent abortion but the results to date 
have been conflicting. The data from a randomized, placebo-controlled 
trial showed that hCG treatment was efficacious only in women with 
oligomenorrhoea. 
           The trend of inhibin and relaxin concentrations closely parallels 
rises in progesterone during early pregnancy. (12) Luteinizing hormone 
(LH) and follicle-stimulating hormone (FSH) levels are suppressed very 
early in pregnancy. The suppression of LH and FSH in hyperstimulated 
cycles is more governed by E2 than inhibin in stimulated cycles. Some 
subjects destined to miscarry exhibit abnormal endocrine changes very 
early in the luteal phase.  
           The adverse effect of a high prepregnancy LH concentration on 
fertility and outcome of pregnancy was seen in primigravidae, women 
with previously successful pregnancies, and women with a history of 
recurrent miscarriage. (13) These data indicate an important role for 
hypersecretion of LH before conception in miscarriage. This finding 
offers the possibility of a simple predictive test for women before 
pregnancy, and could also be used to identify patients with an endocrine 
abnormality that can be remedied.  
            Lejeune B et al, found that elevated antithyroperoxidase (TPO-
Ab) and antithyroglobulin (TG-Ab) antibody titres are associated with an 
increased miscarriage rate. Also, asymptomatic thyroid abnormalities, 
mainly abnormal echo-structure but not antithyroid antibodies, are 
associated with pregnancy induced hypertension. (14) He concluded that 
the presence of thyroid auto-antibodies during pregnancy constitutes a 
marker of increased risk of miscarriage and poor obstetric prognosis. 
.However, Harger JH et al, found that thyroid function profiles provided 
no significant information in the evaluation in these couples. (15)  
 
 
Corpus luteum insufficiency: 
           So far the question as to whether deficient luteal steroidogenesis is 
the cause or the result of an abnormal pregnancy remains unanswered. (16) 
The classic hypothesis put forth by diZerga and Hodgen states that corpus 
luteum insufficiency is a result of aberrant folliculogenesis. Therefore, 
the gestational corpus luteum is unable to respond adequately to the hCG 
signal from the implanting pregnancy. Ottobre and Stouffer also imply 
that gestational corpus luteum insufficiency can result from a delay in 
initiation of hCG rescue. Using their Macaque primate model the authors 
were able to experimentally induce luteal insufficiency by delaying hCG 
rescue by 4 days beyond the normal postovulatory day 7. This opens up 
the possibility that a delay in implantation outside a narrow range of no 
more than 4 days could be a cause of deficient luteal progesterone 
production in pregnancy. Interestingly, transperitoneal and transuterine 
embryo migration have been cited as possible explanations for the 
occurrence of ectopic pregnancies located in the tube contralateral to the 
corpus luteum. It is attractive to postulate that the extended course of 
embryo migration in such cases could cause a delay in implantation and 
corpus luteum rescue and thus explain the low progesterone levels 
frequently seen in ectopic pregnancy. Indeed, to validate this hypothesis 
in future studies, one would need to determine, prospectively, the day of 
implantation and correlate its timing with steroid production in the 
ensuing gestational corpus luteum. It is also interesting to note that based 
on data compiled from the embryological collection of the Carnegie 
Institution, Iffy inferred that the majority of pathological intrauterine, as 
well as extrauterine, pregnancies exhibited evidence supporting a delay in 
the timing of implantation.  
 
Infectioins: 
           Colonization of the lower genital tract with a variety of organisms 
has been associated with pre-term delivery and pre-term premature 
rupture of the membranes. (8) The risk of pre-term delivery is increased in 
women with Neisseria gonorrhoea, Chlamydia trachomatis, Ureaplasma 
urealyticum, Trichomonas vaginalis and bacterial vaginosis. It is 
proposed that ascending infection stimulates a local inflammatory 
response which may in turn trigger a cascade of changes leading to 
cervical change and uterine contractions. 
           Grnِroos MHonkonen et al, found no clear association between 
Chlamydia trachomatis (CT) and abortion, but an association between 
herpes simplex virus (HSV) and abortion is possible. (17)  The incidence of 
raised levels of both CT and HSV IgA antibodies in the cervix was 
surprisingly high in both groups and the significance of this finding 
remains to be investigated.  
          In a prospective study, Hay et al. screened 783 women at low risk 
for pre-term delivery and found that the presence of bacterial vaginosis in 
early pregnancy was associated with second trimester miscarriage and 
pre-term delivery. (18)   Hauth et al. screened a group of 624 women at 
high risk of pre-term delivery for bacterial vaginosis at a mean gestation 
of 22.9 weeks. (19)  The authors randomized patients to treatment with 
metronidazole and erythromycin or placebo. The authors found that 
treatment with erythromycin and metronidazole reduced the rate of pre-
term delivery in women with bacterial vaginosis. These findings were 
confirmed by Morales et al. (20)  A similar study of screening at an earlier 
gestation performed on women with a history of previous second 
trimester miscarriage would provide important information on the value 
of antibiotic treatment in this group.  
Incompetent cervix: 
           Cervical incompetence (cervical weakness) classically presents as 
painless dilatation of the cervix resulting in the rupture of the membranes 
and second trimester miscarriage or early pre-term delivery. (21)  Gaillard 
et al. suggested that cervical incompetence was a factor in 10% of second 
trimester miscarriages. 
             Cervical incompetence has been considered an all-or-nothing 
phenomenon. (22) It has been shown that the length of the cervix is 
inversely related to the risk of pre-term delivery throughout the range of 
lengths supporting the concept of a spectrum of cervical competence. 
 
 
 
 
 
 
 
 
Pregnancy outcome: 
           Hertz JB et al, collected  a group of 93 pregnancies complicated by 
threatened abortion and carefully monitored them throughout pregnancy, 
during birth and in the perinatal period, and any deviation from a 
completely uneventful course was registered. (23) Comparison was made 
with a selected group of 282 non-risk pregnant women. A significant 
association was found between threatened abortion and the overall 
number of complications in the second half of pregnancy requiring 
medical intervention and/or admission to hospital, impending pre-term 
birth requiring betamimetics, pre-term birth, retention of the placenta, 
birth weight below 2000 g, light-for-dates infants in case of pre-term birth 
or birth weight below 2000 g, and hyperbilirubinemia in infants with birth 
weight below 2000 g. The incidences of perinatal mortality and 
congenital malformations did not differ significantly from those of the 
control group. Pregnancies complicated by threatened abortion constitute 
a risk group requiring careful obstetric and perinatal supervision and 
follow-up.  
Miscarriage: 
           Bleeding occurred in one fifth of recognised pregnancies before 
the 20th week and over half of these miscarried. (24) However, the rate of 
miscarriage is influenced to a greater extent by the detection of a positive 
foetal heart activity. Everett CB et al, concluded that, If fetal heart 
movement is detected at the initial scan, approximately 19 out of every 20 
viable pregnancies (those in which the fetus appears normal) will not 
miscarry before the 20th week. (25) Using ultrasound in general practice it 
was possible to identify promptly those women with bleeding whose fetus 
was alive. Where fetal heart movement was detected, there was a good 
prognosis and thus women could be given strong reassurance. Maruo et 
al, found a possible role of thyroid hormones in maintaining early 
pregnancy, and suggest that maternal serum level of thyroid hormone 
may be one of the endocrine factors responsible for the outcome of 
threatened abortion. (26) To evaluate a possible role of thyroid hormones in 
maintaining early pregnancy, serum levels of thyroid hormones, TSH and 
thyroxine-binding globulin (TBG) in 32 patients with a clinical diagnosis 
of threatened abortion were compared between two groups of patients 
with favorable and unfavorable pregnancy outcome. Serum levels of T4, 
T3, free T4 and free T3 levels determined at the onset of clinical signs of 
threatened abortion were found to be significantly lower in patients (N = 
11) who subsequently aborted compared to patients (N = 21) who did not. 
Serum TSH levels did not differ between the two groups. Serum TBG 
levels in the patients who subsequently aborted were lower compared to 
patients with favorable pregnancy outcome. Furthermore, serum levels of 
T4 and T3 at the onset of threatened abortion in patients who 
subsequently did not abort were significantly higher compared to levels 
before pregnancy, whereas little increase in serum T4 and T3 levels 
relative to the pregnant levels was observed at the onset of clinical signs 
in the patients who subsequently aborted.  
Preterm labour: 
           Williams MA et al, assessed the association between first-trimester 
vaginal bleeding and singleton infant outcomes in a hospital-based 
population of 11,444 non-diabetic women, he found that shortened 
gestation occurred more often in women reporting first-trimester bleeding 
than in those who never bled.(27) These relationships remained statistically 
significant after adjusting for confounding factors. Women who 
experienced vaginal bleeding limited to the first trimester (N = 1174) had 
double the risk of delivering a preterm infant compared with those 
experiencing no bleeding (adjusted risk ratio = 2.0; 95% confidence 
interval 1.6-2.5). Current pregnancy symptoms, including vaginal 
bleeding, symptomatic contractions within 2 weeks, and acute or chronic 
lung disease were variably associated with spontaneous preterm delivery 
in nulliparous and multiparous women. (28) The association between early 
pregnancy vaginal bleeding and preterm delivery is also confirmed by 
Meis PJ et a,l (29) 
Foetal growth: 
           Das AG et al, conducted a study to find out the effect of threatened 
abortion in the current pregnancy on the subsequent perinatal outcome 
and follow the growth pattern of the fetuses of such complicated 
pregnancies. (30) The study group consisted of 55 women with threatened 
abortion and 55 women with normal pregnancies formed the control 
group. Most of the patients presented at 6-12 weeks' gestation. The fetal 
growth was monitored by both clinical as well as ultrasound (USG) 
parameters. The mean growth rates were almost identical throughout 
gestation. The mean values of each parameter of the study group were 
found lying with 95% confidence limit values of their control group. In 
contrast to this, Williams MA et al,found that LBW occurred more often 
in women reporting first-trimester bleeding than in those who never bled. 
(27)  Bleeding limited to the first trimester was associated with a 1.6-fold 
risk of delivery of a term LBW infant (95% confidence interval 1.3-2.0). 
In a population based study, Mulik V et al, found that the incidence of 
low and very low birth weight deliveries, although significantly higher 
compared with the control population, was not affected independently by 
this early pregnancy complication on logistic regression (OR 1.3, 0.8 -
 1.9). (3) 
Antepartum haemorrhage: 
           Threatened miscarriage was associated independently with an 
increased incidence of abruption (OR 2.8, 2.0 - 3.7), unexplained 
antepartum haemorrhage (APH) (OR 2.3, 1.1 - 5.1). (3) All forms of APH 
were significantly higher in term deliveries complicated by threatened 
miscarriage  
 
Foetomaternal hemorrhage: 
           Von Stein GA et al compared the incidence of Foetomaternal 
hemorrhage between patients with threatened abortion and a control 
population of similar gestational age. (31) The amount of Foetomaternal 
hemorrhage was evaluated using the Kleihauer-Betke acid elution assay. 
A positive result in his laboratory, as determined by a nonpregnant 
control group, was a value of 0.07% or more fetal cells. Using this 
criterion, 11% of the study population had a positive Kleihauer-Betke 
test, compared with 4% in the pregnant control group. Anti-(D) 
immunoglobulin may be indicated in Rho(D)-negative patients who 
present with threatened abortion. 
 
Perinatal morbidity and mortality: 
           The early neonatal mortality rates were significantly higher in the 
threatened miscarriage group, which on logistic regression was due 
independently to preterm delivery, placental abruption and low birth 
weight deliveries (3) 
  
Outcome prediction in threatened miscarriage: 
CA-125 
           CA-125 may serve as an accurate predictor of the outcome in early 
pregnancies with demonstrable fetal heartbeat, which are complicated by 
bleeding. In the five patients who eventually aborted, the values of CA-
125 were > 125 U/mL, whereas none of the successful pregnancies had a 
value > 93 U/mL. (32) The mean values were 133 +/- 4.85 versus 36.95 +/- 
23.1 U/mL for miscarriages and successful pregnancies, respectively. In 
normal pregnancies the respective value was 32.3 +/- 4.3 U/mL. No 
statistically significant difference was observed with respect to the 
duration of vaginal bleeding between the aborters and the patients with a 
favorable outcome. Nevertheless, when vaginal bleeding had been present 
for 3 days or more and there was high maternal serum CA125 activity, 
the abortion risk was found to be 100%. These findings suggest that the 
maternal serum CA125 measurement in threatened abortion can be useful 
to determine the extent of decidual destruction which is directly related to 
the outcome of pregnancy. 
 
Pregnancy-associated plasma protein A (PAPP-A): 
            Depressed pregnancy-associated plasma protein A (PAPP-A) 
concentrations have been found in patients with threatened abortion, often 
weeks before spontaneous abortion while the fetus was still alive. (33) In 
order to extend these findings Ruge S et al, developed a highly sensitive 
PAPP-A radio-immunoassay and have established a reference range in 
early pregnancy for PAPP-A between week 7 and week 20 of pregnancy, 
the serum values of PAPP-A were significantly lower (p = 0.002) in the 
group of women with vaginal bleeding than in the group of normally 
pregnant women. However, with regard to abortion later on, the 
predictive value of an abnormal blood test on admission was only 18.7%. 
Serial determinations showed increased PAPP-A values corresponding to 
the centile expected in women who aborted, as well as in women who 
gave birth. Consequently, the test is of no clinical value in the assessment 
of the prognosis in patients with symptoms of threatened abortion. 
 
Immunoglobulins IgG, IgA and IgM: 
           Mean values of IgG, IgA and IgM of serum and uterine blood were 
significantly higher in women with spontaneous abortion than in women 
with delivery. (34)  Prognosis of threatened abortion is more unfavourable, 
if concentrations of immunoglobulins in serum and especially in uterine 
blood increase.  
           Hertz JBSchultz & Larsen P estimated the predictive value of 
HPL, SP1 and AFP in serum of women admitted to hospital because of 
vaginal bleeding in the 6th to 19th gestational week. (35) The prediction of 
abortion based on the initial analysis from the day of admission was 
found to be 91.7%, 75.9% and 81.8% for HPL, SP1 and AFP, 
respectively. The corresponding values for prediction of successful 
outcome were 68.7%, 73.6% and 65.4%. The HPL and AFP 
determinations were, however, found to be valid only after the 9th and 
12th gestational week, respectively. A highly significant positive 
correlation (r = 0.84, P less than 0.001) was demonstrated between HPL 
and SP1 suggesting that SP1 measurements might replace HPL in the 
evaluation of the prognosis in threatened abortion.  
Diagnosis: 
           Bleeding in the first trimester can originate from the uterus, cervix, 
or vagina, or it can be extragenital. (1) Thorough physical examination is 
essential to differentiate between genital and extragenital causes. 
Extragenital causes should be ruled out by speculum examination. 
Bimanual examination of the uterus will determine whether the uterine 
size is consistent with the clinical dating. A large uterus may indicate 
hydatidiform mole, whereas a small uterus suggest a blighted ovum. The 
presence of a tender adnexal mass suggests an ectopic pregnancy.  
Sonographic evaluation:  
           Sonography can usually differentiate between an intrauterine 
pregnancy (viable or non-viable), a molar pregnancy, or an inevitable 
abortion. (2) Furthermore, sonographic features of pregnancy have been 
proposed as predictors. An empty gestational sac with a diameter of at 
least 15 mm at seven weeks and 21 mm at eight weeks has diagnostic 
accuracy of 90.8% in predicting miscarriage in women with symptoms. A 
mean sac diameter of at least 17 mm without an embryo or 13 mm 
without a yolk sac can predict non-viable gestation with a specificity and 
a positive predictive value of 100%. Fetal heart activity should be visible 
with transvaginal sonography once the fetal pole is at least 5 mm long.w5 
Most prospective series report a loss rate of 3.4-5.5% if bleeding occurs 
after fetal heart activity starts, and identification of fetal heart activity by 
ultrasound in primary healthcare settings carries a 97% likelihood for the 
pregnancy continuing beyond 20 weeks. However, this favourable effect 
has not been universally repeated, as miscarriage rates of 20-30% have 
been reported. http://bmj.bmjjournals.com/cgi/content/full/329/7458/152 - FIG1 
Fetal bradycardia and discrepancy between gestational age and crown to 
rump length are adverse prognostic factors. Prospective data indicate that 
the presence of any of three risk factors (fetal bradycardia, discrepancy 
between gestational sac and crown to rump length, and discrepancy 
between menstrual and sonographic age by more than one week) 
increases the rate of abortion from 6% when none are present to 84% 
when all three are present.  
           The prognostic value of a subchorionic haematoma in ultrasound 
has been disputed. (2) Although a large separation has been associated with 
about a threefold increase of risk of miscarriage (19% v 71%) in women 
with bleeding, the presence or the size of haematoma did not affect 
miscarriage rate (10% v 11%) in another prospective series, and other 
studies reported similar findings. A prospective study of 6675 women 
found that the presence of an intrauterine haematoma in the first trimester 
of pregnancy increases the risk of severe obstetric complications, 
irrespective of the presence of symptoms of threatened miscarriage. 
However, the presence of a haematoma did not influence the risk for 
subsequent complications in a smaller study of symptomatic women.  
Management: 
           Because most physicians consider any bleeding in early pregnancy 
to be a sign of threatened abortion, any treatment of so-called threatened 
abortion has a considerable likelihood of success.(4) Most women who 
actually are threatening to abort progress normally no matter what is 
done. If, however, bleeding is attributable to one of the unrelated causes 
mentioned above, it is likely to disappear, regardless of treatment. 
 Insitu IUCD: 
 If an intrauterine device is still present and the “string” is visible, the 
device should be removed for reasons cited in. (4)  
Bed rest: 
           Bed rest is used in nearly 20% of all pregnancies to prevent or treat 
a wide variety of conditions, including spontaneous abortion, preterm 
labor, fetal growth retardation, edema, chronic hypertension, and 
preeclampsia. There is little evidence of effectiveness. (36)  
           In one study, 1228 out of 1279 (96%) general practitioners 
prescribed bed rest for heavy bleeding in early pregnancy, although only 
an eighth of them felt it was mandatory, and only one third felt it could 
affect outcome. (37) Only one randomised controlled trial considers the 
impact of bed rest on the course of threatened miscarriage. (38) 61 women 
with viable pregnancies at less than eight gestational weeks and vaginal 
bleeding were randomly allocated into either injections of hCG, injections 
of placebo, or bed rest. The abortion rates in the three groups were 30%, 
48%, and 75%—significant differences between hCG and bed rest groups 
but not between hCG and placebo groups or between placebo and bed rest 
groups. Although hCG performed significantly better than bed rest in this 
study, the lack of profound benefit over placebo, the concern about 
potential development of ovarian hyperstimulation syndrome, and the fact 
that threatened miscarriage may be the result of various conditions, 
irrelevant to luteal function, prevented further testing and application of 
hCG treatment in general obstetric practice.  
           In a retrospective study of 226 women who were hospitalised for 
reasons related to their pregnancy and previous threatened miscarriage, 
16% of 146 women who were bed resting eventually miscarried, 
compared with a fifth of women who did not follow this option (not 
significant; P = 0.41).(39) In contrast, a recent observational cohort study of 
230 women with threatened miscarriage who were recommended bed rest 
showed that women who adhered to this suggestion had a miscarriage rate 
of 9.9%, compared with 23.3% of women who continued their usual 
activities (P = 0.03). (40)  The duration of vaginal bleeding, haematoma size 
and gestational age at diagnosis did not influence miscarriage rate. 
Although there is no definite evidence that bed rest can affect the course 
of pregnancy, abstinence from active environment for a couple of days 
may help women feel safer, thus providing emotional relief. 
Progestogen therapy: 
           Two recently published meta-analyses of controlled trials of a 
wide variety of progestational agents, used in pregnancy (Daya 1989; 
Goldstein et al. 1989), prompted this third meta-analysis of placebo-
controlled trials involving the prophylactic use of a single agent, 17 
alpha-hydroxyprogesterone caproate. (41) Of seven relevant published 
reports of controlled trials, six had involved women considered to be a 
high risk of miscarriage or preterm birth. This analysis provides no 
support for the view that 17 alpha-hydroxyprogesterone caproate protects 
against miscarriage, but suggests that it does reduce the occurrence of 
preterm birth. The latter effect was reflected in a reduced rate of low 
birthweight babies, but not in a statistically significant reduction in 
perinatal mortality and morbidity. The difference between this meta-
analysis and the two earlier meta-analyses illustrates the problems both of 
selective sub-grouping and of comprehensive pooling of data from small 
trials. 
           The continued use of progestational agents in attempts to achieve a 
normal outcome of pregnancy in women with a ’high-risk’ pregnancy 
(previous miscarriage, stillbirth or present preterm labour) prompted this 
meta-analysis of randomized control trials of such therapy. (42) Of 20 trials 
of a progestogen 15 had combinable data. Combined comparisons, using 
odds ratios with confidence intervals, were made of the rates of livebirths 
at term or preterm and the sum of term and preterm deliveries, 
miscarriages, stillbirths and neonatal deaths. All but one comparison 
failed to show a significant benefit 
           Progesterone is prescribed in 13-40% of women with threatened 
miscarriage, according to published series. (3) Progesterone is the main 
product of the corpus luteum, and giving progestogen is expected to 
support a potentially deficient corpus luteum gravidarum and induce 
relaxation of a cramping uterus. The evidence on progesterone is of low 
quality. Recently, a meta-analysis assessed the impact of progesterone 
supplementation on miscarriage rate in various clinical settings however, 
it did not provide a separate analysis for progesterone in threatened 
miscarriage. Four published papers in the meta-analysis were assessing 
this relationship, one of them including three different regimens of 
progestogen, and those data were reanalysed. Having miscarriage as 
outcome, random effects risk ratio was 1.10 (95% confidence interval 
0.92 to 1.31) for progestogens group. In the only studies that provided 
sonographic evidence of fetal heart activity at presentation, the relative 
risk for miscarriage was 1.09 (90% confidence interval 0.90 to 1.33) for 
the progestogen group. Thus, given the poor quality of the data, 
progesterone does not seem to improve outcome in women with 
threatened miscarriage. However, local application of a progestogen was 
found to subjectively decrease uterine cramping more rapidly than bed 
rest alone in one small study.  
Buphenine hydrochloride:  
           Buphenine hydrochloride a vasodilator and  muscle relaxant as 
well was used by Soltan MH in a placebo controlled study, in women 
with threatened miscarriage.(43) Pregnancy continuation was 90.6% in the 
Buphenine group and 62.3% in the placebo group. He concluded that 
Buphenine hydrochloride was better than placebo  
Rh prophylaxis: 
           Dayton VD et al, described a patient whose history suggests 
development of an anti-D antibody after first-trimester bleeding. . (44)To 
his knowledge, that was the first such case reported in the English 
literature. Women who are D negative with a threatened abortion 
probably should receive anti-D immunoglobulin. Von Stein and 
associates (1992) reported that more than 10 percent of their patients had 
significant fetomaternal hemorrhage. (4) 
 
 
 
 
 
 
 
 
 
 
 
 Objectives : 
 
 
This study was conduced to address the effects of bleeding in early 
pregnancy regarding the followings                                                  
1. The association between bleeding in early pregnancy and risk of 
preterm labour . 
2. The association between bleeding in early pregnancy and risk of 
intrauterine growth restriction (IUGR). 
3. The effects of bleeding in early pregnancy on the perinatal 
morbidity and mortality . 
4. The association between bleeding in early pregnancy and   
bleeding in 3rd trimester (APH). 
 
 
 
 
Patients and Methods : 
 
     This is a hospital based prospective cohort study conducted on patients 
with bleeding in early pregnancy (1st and 2nd trimesters) in Khartoum 
teaching hospital (KTH) and Soba University hospital (SUH). In the 
period from  June 2003 to June 2004 . 
 
Study area : 
      This study was carried out in KTH and SUH . KTH is the biggest 
governmental hospital that belongs to ministry of health .It serves a large 
area including KRT state  and wide area surrounding it . It accepts 
booked , referred and casualty patients .It consists of six units shared by 
ministry of health (3 units )and faculty of medicine , university of KRT 
(3units) . Each unit is covered by a senior consultant and two specialist , 
registrars  and house officers working 24 hours . 
     SUH is one of the  specialized hospital in Sudan which belongs to 
university of KT , it serves Khartoum and Gesira states , it is the only 
hospital which has a specialized foetal unit and received high risk patients 
from all over Sudan. 
 
Study population:- 
 
     The study population includes 103 cases with bleeding in early 
pregnancy attending KTH casualty and SUH referred clinic and labour 
room,  and 205 control patients . Every case was matched with two 
controls of same  age group  and parity . 
    The cases and controls were followed up regularly in antenatal clinics 
and in the wards wherever a complication occurred . All patients were 
followed during labour and early postnatal  period till time of discharge in 
collaboration   with the  neonatologist . 
Inclusion criteria :  
1. Patient should be pregnant < 24 weeks at time of presentation . 
2. The viability of the baby at the time of presentation should be 
confirmed . 
3. Singleton pregnancies were included . 
 
Exclusion criteria : 
1. Patients with missed abortion , multible pregnancy and molar 
pregnancy (Partial mole )were excluded . 
2. Patient with Inevitable  and complete abortion were also 
excluded. 
 
Data collection: 
 
    Data were collected by questionnaire at the time of presentation which 
was filled by resident registrar in casualty  and labour room after 
checking that the patients were fulfilling the inclusion and exclusion 
criteria . 
  
Data analysis  
  
      Information were entered in computer system for analysis using SPSS 
soft ware . 
 
 
 
 
 
 
The Results 
      103 patients with bleeding in early pregnancy (1st , 2nd trimesters ) 
attended to SUH , were enrolled  in the study after fulfilling the inclusion 
and exclusion criteria . 
    These cases were followed throughout pregnancy and labour and  
delivery and early post natal period. These patients were compared with 
205 controls  with same parity and age.  Of  these 103 patient with  
bleeding in early pregnancy , 17 cases (16.5%) had bleeding in early in 1st 
trimester and the rest (86 cases (63.5%)had there first episode of bleeding 
in 2nd trimester Fig(7) . The majority of patients had one episode of 
vaginal bleeding (72.8%) in comparison to (18.4%) which had two 
episodes and ( 7.8%)  which has three or more episodes. 
     37 patients of cases (35.9%) delivered prematurely in comparison to 
16 patients in the controls (7.81%) which delivered premature 
labour(P=.003)  which was statistically significant in patient with 
bleeding in early pregnancy in comparison with the controls . 
     22 patients out of 75 patients  with one episode of vaginal bleeding 
delivered prematurely (29.3%) . 
    Ten patients out of 19 patients with two episodes delivered prematurely 
(52.6%) .  
    Five patients out of nine with three  or more episodes delivered 
prematurely (55.6%) fig 8.  
    Out of 66 patients who reach term in patients with bleeding in early 
pregnancy (9%) have birth wt < 2.5kg in comparison to ( 4  %)   out of 
189 patients  who reach term in the control group. 
    The perinatal outcome in 90 patients (87.4%) delivered alive and well 
babies in comparison to 199 (97.1%) in control groups . The fresh still- 
birth in cases were 9(8.7%)in comparison to2 on the control groups ( 1%) 
The macerated still -birth were 4(3.9%)  and 4(2%) respectively in cases 
and control .These differences  were statistically significant (P=0.001) . 
      Regarding the risk of antepartum  haemorrhage 7out of   103 cases 
(6.8%) developed APH in comparison  to 2 out of 205 (1%) of the control 
group . This difference is statistically significant (P=0.004) . 
     Considering the risk of  congenital malformations 5 patients  out of 
103 cases( 4.9%) delivered a congenitally malformed baby in contrast to 
4 patient out of 205( 2%% ) on the control group . This difference is not 
statistically significant (P= 0.154). 
• Concerning infertility , there were 19 cases with a history of 
infertility  (18.4 %) compared to 11 cases in the control groups 
(5.4%) making a significant association between a history of 
infertility and early pregnancy bleeding (P= 0.001). 
• There was no association between history of previous miscarriage 
and the occurrence of bleeding in early pregnancy (P= 0.68). 
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Table (1): Gestational age at time of delivery 
 
 
 
 
Gestational 
age 
 
Cases Control Total Percentage 
Term  
 
66(64.1%) 189(92.2%) 255 (82.8%) 
Preterm 
 
37(35.9%) 16(7.8%) 53 (17.2%) 
Total 
 
(103)100% 205(100%) 308 (100%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table (2):Perinatal Outcome In The study Population 
 
 
 
 
Perinatal Outcome 
 
Cases 
 
Controls 
 
Total  
 
% 
Alive & well 
 
90(87.4%) 199(97%) 289 93.8% 
Fresh still birth  
 
9(8.7%) 2(1%) 11 3.6% 
Macerated still birth 
 
4(3.9%) 4(2%) 8 2.6% 
 Total 
 
103(100%) 205 308 308 
Percentage 
 
100% 100% 100% 100% 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table(4) :The Incidence Of Antepartum Haemorrhage: 
 
 
APH  
 
Cases Control Total % 
APH + 
 
07(6.8%) 02(1%) 9 3% 
No APH  
 
96(93.2%) 203(99%) 299 97% 
Total 
 
103(100%) 205(100%) 308(100%) 100% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table(5): The Incidence Of Congenital Malformations 
 
 
Congenital 
malformations  
 
Cases Control Total % 
malformed 
 
05(4.9%) 02(1%) 9 3% 
Not malformed 
 
98(95.1%) 201(99%) 299 97% 
Total 
 
103(100%) 205(100%) 308(100%) 100% 
 
 
 
 
 
 
 
Fig.1: Age distribution of the study cases
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Fig.2: Distribution of the study cases according 
to the working state
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Fig.3: Distribution of the study cases according 
to the level of education
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Fig.5: History of subfertility among the study 
cases
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Fig.6: Amount of vaginal bleeding among the 
study cases
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Heavy bleeding Light bleeding
 
 
 
 
 
 
 
Fig.7: Distibution of the study cases according 
to the time of vaginal bleeding
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Fig.8: Frequency of vaginal bleeding in the 
study cases
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Discussion 
 
This cohort study was conducted to show the adverse outcomes 
and the effects of first and 2nd trimesters bleeding on the outcome of 
pregnancy which proceeds  beyond the episode of bleeding .                      
The results showed that bleeding in early pregnancy was associated 
with increased risk of preterm labour and delivery  over those without any 
episode  of vaginal bleeding in the 1st  and 2nd  trimester .(35.9%Vs  
7.8%) . 
The risk is proportional  to the number  of bleeding episodes . 
Hertz JB etal found a significant association between threatened  abortion 
and preterm birth (23) . Williams MA etal  found that shortened gestation 
was more often in women reporting 1st trimester bleeding than in those 
who never bleed (23) .  
The association between early pregnancy bleeding and preterm 
delivery was also confirmed by Meis PJetal (29).  
Lastly Everett CB etal, arrived to the same conclusion but linked 
the final  outcome of pregnancy to the viability of the fetus  at the time of 
the bleeding episode (24). 
Regarding  foetal growth , the  study revealed an increased number 
of babies whose weight was less than 2.5 kg at term compared to those in 
the control groups (    9%   Vs    4%    )   . 
Das AG etal , found that the mean growth rates were almost 
identical throughout gestation in the study and control groups (30). 
      In contrast to this , Williams MA etal , found  a significant association 
between first trimester bleeding and LBW (27). 
Mulik V etal , also found an increased risk of LBW in association  
with early pregnancy bleeding (3). 
Our study showed a significant association between antepartum 
haemorrhage in those cases of early pregnancy bleeding (6.8%Vs 1%) . 
Mulik V etal found an increased incidence of all forms of APH in 
term deliveries complicated by threatened miscarriage  including 
unexplained APH (3). 
There was a statistically significant difference in the occurrence of 
FSB between  the cases complicated by early vaginal bleeding and those 
with out in our study (8.7%Vs 1%). 
There was no significant difference regarding the occurrence of 
MSB between the cases and the control group . 
Mulik v, Bethes ) , and Bhal K.A.found a higher rate of perinatal  
morbidity and mortality in  cases complicated by early pregnancy 
bleeding and attributed that to preterm delivery , placental abruption and 
low birth weight (3). 
In our study there was no effect of bleeding in early pregnancy on 
the occurrence of congenital malformation . 
We found a statistically significant association between the 
occurrence of bleeding in early pregnancy and history of infertility 
(18.4% Vs 5.4%) , (P=.001). 
There was no link between previous miscarriage and the 
occurrence of bleeding in early pregnancy . 
Regarding afeto-maternal haemorrhage,  Van Stein GA etal found 
a significant feto-maternal haemorrhage in cases  complicated by early 
vaginal bleeding compared to control groups (11%Vs +4 %)and 
recommended  anti- Dfor  Rh-(D)negative patient with threatened  
abortion .  
 
 
Conclusion :  
 
 
• Bleeding in early pregnancy is associated with increased risk of 
preterm delivery . 
• Bleeding in the 1st and 2nd trimesters is associated with increased 
risk of intrauterine growth restriction . 
• 1st and 2nd trimester bleeding is associated with increased risk of 
perinatal morbidity and mortality . 
• Bleeding in the 1st half of pregnancy is associated with increased 
risk of a abruption,  placenta previa and unexplained APH. 
• There is no increased in congenital anomalies in babies whose 
mothers were affected by bleeding in the 1st half of pregnancy . 
• All these risks are increased in proportion to the number of 
episodes of vaginal bleeding in the 1st and 2nd trimester . 
 Recommendations :- 
 
• Pregnancy complicated by 1st and 2nd trimesters bleeding should 
be considered as a high risk pregnancy and managed accordingly. 
• All patients  with early pregnancy bleeding should be managed in 
a center where there are facilities for NCU to deal with the cases 
of  prematurity and intrauterine growth restricted  babies . 
• Blood bank facilities should be available as there is increased risk 
of ante-partum haemorrahage. 
• We should adopt a programme for delivering anti.D 
immunoglobulin to those who need it in the proper  dose and time 
as there is a significant risk of feto-maternal  haemorrhage in Rh-
ve patients. 
• Neonatolgist  supervision of new born babies should be available 
. 
• There should be a reliable method for detection of the outcome of 
pregnancies complicated by early vaginal bleeding such as CA-
125 – PAPP – A and immunological  tests. 
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